263
Participants
Start Date
June 23, 2017
Primary Completion Date
September 30, 2020
Study Completion Date
December 18, 2020
brief Motivational Interviewing
"All study participants will receive daily dosing text message reminders.~Participants randomized to the MI-b Intervention and who are persistently non-adherence based on negative or non-responses to iTAB will be sent automated high alert messages notifying the participant to take their study medication and respond to iTAB. Both the study coordinator and the MI counselor will also receive the high alert message. Participants will be contacted by the MI counselor for a phone MI-b session within 72 hours of a high alert message to discuss adherence. Participants who continue to be non-adherent despite receiving these messages will be switched to receive alert messages on a monthly schedule."
Los Angeles Lesbian, Gay, Bisexual, and Transgender Center, Los Angeles
University of Southern California, Los Angeles
LA Biomed at Harbor-UCLA, Torrance
Family Health Centers of San Diego, San Diego
University of California, San Diego, San Diego
University of Southern California
OTHER
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
OTHER
Los Angeles LGBT Center
OTHER
Family Health Centers of San Diego
OTHER
University of California, San Diego
OTHER